Are you Dr. Pipas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Department of Hematologyoncology
Lebanon, NH 03756Phone+1 603-650-9474
Summary
- Dr. J. Pipas, MD is an oncologist in Lebanon, New Hampshire. He is currently licensed to practice medicine in New Hampshire.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1992 - 1994
Medical University of South CarolinaResidency, Internal Medicine, 1989 - 1992
SUNY Upstate Medical UniversityClass of 1989
Certifications & Licensure
NH State Medical License 1994 - 2022
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Start of enrollment: 2009 Sep 01
- A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2008 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 867 citationsA randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.Robert S. Sandler, Susan Halabi, John A. Baron, Susan Budinger, Electra D. Paskett
The New England Journal of Medicine. 2003-03-06 - 206 citationsRandomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With...Herbert Hurwitz, Nikhil Uppal, Stephanie Ann Wagner, Johanna C. Bendell, J. Thaddeus Beck
Journal of Clinical Oncology. 2015-09-08 - 91 citationsPancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults.Timothy B. Gardner, Lisa M. Glass, Kerrington D. Smith, Gregory H. Ripple, Richard J. Barth
The American Journal of Gastroenterology. 2013-10-01
Press Mentions
GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee ReviewJuly 31st, 2024- Update: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee ReviewJuly 31st, 2024
